Our study was conducted with a duration of 16 weeks of treatment, which is similar to the trials already present in the literature which evaluated biological drugs in monotherapy for the management of multiple allergies, showing a statistically significant reduction in the total sum of specific IgE for trophoallergens and molecular food allergens for component resolved diagnosis. Here, IGHE is linked to allergic disease.